Leon O Moulder Jr Net Worth - Insider Trades and Bio as of Jan 20, 2026

Leon O Moulder Jr's Net Worth

$89.2 Million

Estimate Recalculated Nov 7, 2024 04:53PM EST

Who is Leon O Moulder Jr

Leon O Moulder Jr has an estimated net worth of $89.2 Million. This is based on reported shares across multiple companies, which include TESARO, Inc., Abraxis BioScience, Inc., Zai Lab Ltd, TREVENA INC, CUBIST PHARMACEUTICALS INC, Dianthus Therapeutics, Inc. /DE/, and MGI PHARMA INC.

SEC CIK

Leon O Moulder Jr's CIK is 0001228865

Past Insider Trading and Trends

2014 was Leon O Moulder Jr's most active year for acquiring shares with 9 total transactions. Leon O Moulder Jr's most active month to acquire stocks was the month of May. 2008 was Leon O Moulder Jr's most active year for disposing of shares, totalling 12 transactions. Leon O Moulder Jr's most active month to dispose stocks was the month of December. 2009 saw Leon O Moulder Jr paying a total of $9,492,000.00 for 250,000 shares, this is the most they've acquired in one year. In 2019 Leon O Moulder Jr cashed out on 2,482,517 shares for a total of $77,599,800.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

TESARO, Inc.

Chief Executive Officer

Updated Jan 22, 2019


Form 4	-100.00%	-2.49M	$75.00	-$77.97M	Jan 22, 2019	—	Disposition	—	Jan 22
Form 4	12.89%	137.87K	—	—	Mar 05, 2018	1.21M	Options	—	Mar 01
Form 4	—	5.00K	$56.93	$284.64K	Mar 05, 2018	1.02M	Purchase	—	Mar 02
Form 4	3.55%	37.50K	—	—	Mar 03, 2017	1.09M	Options	—	Mar 01 - Mar 01
Form 4	—	150.00K	—	—	Mar 03, 2016	150.00K	Grant	—	Mar 01
Form 4	—	140.00K	—	—	Mar 10, 2015	140.00K	Grant	—	Mar 06
Form 4/A	—	125.00K	—	—	Mar 07, 2014	125.00K	Grant	—	Feb 27
Form 4	62.50%	125.00K	—	—	Mar 04, 2014	325.00K	Grant	—	Feb 27
Form 4	—	200.00K	—	—	Mar 08, 2013	200.00K	Grant	—	Mar 06
Form 4	1.00%	10.00K	$11.69	$116.90K	Aug 31, 2012	1.01M	Purchase	—	Aug 30
Form 4	-51.81%	-1.07M	—	—	Jul 06, 2012	996.43K	Options	—	Jul 03
Form 3	—	—	—	—	Jun 27, 2012	567.86K	—	—	—

Showing 12 results

Abraxis BioScience, Inc.

President & CEO

Updated May 01, 2009


Form 4	—	250.00K	$47.46	$9.49M	May 01, 2009	250.00K	Grant	—	Apr 29
Form 3	—	—	—	—	May 01, 2009	—	—	—	—

Showing 2 results

Zai Lab Ltd

Investor

Updated Jun 20, 2024

View Quote Details


Form 4	52.45%	21.25K	—	—	Jun 20, 2024	61.77K	Grant	—	Jun 18
Form 4	87.45%	18.90K	$26.45	$499.98K	Jun 30, 2023	40.52K	Grant	—	Jun 29
Form 4	56.04%	7.76K	—	—	Jan 04, 2022	21.62K	Grant	—	Jan 03
Form 4	38.52%	3.85K	—	—	Jan 20, 2021	13.85K	Grant	—	Jan 15
Form 3	—	—	—	—	Jan 04, 2021	10.00K	—	—	—

Showing 5 results

TREVENA INC

Investor

Updated Jun 20, 2023

View Quote Details


Form 4	—	13.70K	—	—	Jun 20, 2023	13.70K	Grant	—	Jun 15
Form 4	—	100.00K	—	—	Jun 13, 2022	100.00K	Grant	—	Jun 09
Form 4	—	68.58K	—	—	Jun 02, 2021	68.58K	Grant	—	May 28
Form 4	—	64.10K	—	—	May 15, 2020	64.10K	Grant	—	May 13
Form 4	—	30.00K	—	—	May 16, 2019	30.00K	Grant	—	May 16
Form 4	—	100.00K	$1.02	$102.00K	Feb 04, 2019	150.00K	Purchase	—	Feb 01
Form 4	—	30.00K	—	—	May 17, 2018	30.00K	Grant	—	May 16
Form 4	—	15.00K	—	—	Jun 06, 2017	15.00K	Grant	—	May 17
Form 4	—	15.00K	—	—	May 19, 2016	15.00K	Grant	—	May 18
Form 4	—	8.87K	—	—	May 21, 2015	8.87K	Grant	—	May 20
Form 4	—	50.00K	$4.00	$199.98K	Dec 10, 2014	50.00K	Purchase	—	Dec 09 - Dec 10
Form 4	—	8.87K	—	—	May 15, 2014	8.87K	Grant	—	May 14
Form 3	—	—	—	—	Jan 30, 2014	—	—	—	—

Showing 13 results

CUBIST PHARMACEUTICALS INC

Investor

Updated Jan 21, 2015


Form 4	-100.00%	-79.55K	$102.00	-$1.13M	Jan 21, 2015	—	Disposition	—	Jan 21
Form 4	86.14%	8.79K	—	—	Jun 05, 2014	18.99K	Options	—	Jun 03
Form 4	129.20%	10.47K	—	—	Jun 14, 2013	18.57K	Grant	—	Jun 12
Form 4	—	—	—	—	Jun 11, 2013	8.10K	Options	—	Jun 06
Form 4	196.96%	11.59K	—	—	Jun 11, 2012	17.47K	Grant	—	Jun 06
Form 4	566.25%	5.00K	$36.78	$183.89K	Nov 08, 2011	5.88K	Purchase	—	Nov 04
Form 4	3,295.08%	10.05K	—	—	Jun 06, 2011	10.36K	Grant	—	Jun 02
Form 4	—	16.82K	—	—	Jun 14, 2010	16.82K	Grant	—	Jun 10
Form 4	—	16.83K	$20.96	$352.82K	Feb 22, 2010	16.83K	Grant	—	Feb 18
Form 3	—	—	—	—	Feb 22, 2010	—	—	—	—

Showing 10 results

Dianthus Therapeutics, Inc. /DE/

Investor

Updated May 28, 2024

View Quote Details


Form 4	—	11.00K	—	—	May 28, 2024	11.00K	Grant	—	May 23
Form 4	13.12%	166.67K	$12.00	$2.00M	Jan 24, 2024	1.44M	Grant	—	Jan 22
Form 4	—	6.50K	—	—	Sep 13, 2023	6.50K	Grant	—	Sep 11
Form 3	—	—	—	—	Sep 13, 2023	1.27M	—	—	—

Showing 4 results

MGI PHARMA INC

President & CEO

Updated Jan 30, 2008


Form 4	-100.00%	-1.04M	$35.47	-$27.64M	Jan 30, 2008	—	Disposition	—	Jan 28
Form 4	-91.98%	-200.74K	$41.00	-$8.23M	Jan 25, 2008	17.50K	Disposition	—	Jan 23
Form 4/A	-0.78%	-1.64K	$23.57	-$38.54K	Dec 19, 2007	218.24K	Tax	—	Aug 31
Form 4	-0.78%	-1.64K	$23.57	-$38.54K	Sep 05, 2007	217.54K	Tax	—	Aug 31
Form 4	-4.56%	-10.00K	—	—	Jun 29, 2007	219.18K	Grant	—	Jun 29
Form 4	-1.18%	-2.62K	$21.14	-$55.30K	May 11, 2007	229.18K	Tax	—	May 10
Form 4	—	85.00K	$22.87	$1.94M	Feb 22, 2007	316.79K	Grant	—	Feb 20
Form 4	49.53%	100.00K	$15.13	$1.21M	Sep 01, 2006	311.42K	Grant	—	Aug 31
Form 4	1.00%	2.00K	$14.16	$28.31K	Aug 07, 2006	212.12K	Purchase	—	Aug 04
Form 4	-0.20%	-411.00	$20.58	-$8.46K	Jul 17, 2006	210.12K	Tax	—	Jul 15
Form 4	1.01%	2.00K	$18.84	$37.69K	Oct 28, 2005	209.61K	Purchase	—	Oct 27
Form 4	2.58%	5.00K	—	—	Jul 18, 2005	207.61K	Grant	—	Jul 15
Form 4	—	—	$4.02	—	Jan 27, 2005	1.93M	Options	—	Jan 25
Form 4/A	664.00%	332.00K	$59.21	$18.95M	Jul 02, 2004	386.07K	Grant	—	May 10
Form 4	664.00%	332.00K	$59.21	$18.95M	May 12, 2004	386.07K	Grant	—	May 10

Showing 15 results

Zenas BioPharma, Inc.

Chief Executive Officer

Updated Sep 17, 2024

View Quote Details


Form 4/A	-53.79%	-3.84M	—	—	Sep 17, 2024	3.30M	Options	—	Sep 12 - Sep 16
Form 4	-63.79%	-3.84M	—	—	Sep 16, 2024	2.18M	Options	—	Sep 12 - Sep 16
Form 3	—	—	—	—	Sep 12, 2024	1.12M	—	—	—

Showing 3 results